Document Detail

Development of a cell immobilization technique for the conversion of polysialogangliosides to monosialotetrahexosylganglioside.
MedLine Citation:
PMID:  21500968     Owner:  NLM     Status:  Publisher    
Context: Monosialotetrahexosylganglioside (GM(1)) prepared from the brain of pig or bovine is an effective clinical drug in the treatment of different nervous system diseases. Generally, polysialogangliosides are transformed into GM(1) by enzymic or chemical hydrolysis due to the very poor level of natural GM(1). Objective: To continuously obtain GM(1) by cell immobilization in a packed-bed reactor. Materials and methods: Brevibacterium casei, which is Gram-positive bacteria belonging to the order Actinomyces and family Brevibacteriaceae, can produce high-activity sialidase, are encapsulated in silk fibroin hydrogel, and subsequently packed into a reactor. The crude ganglioside is pumped into the reactor and continuously turned to GM(1). Results: The optimal silk fibroin concentration for hydrogel preparation is 6.0% (w/v). The optimal initial biomass for immobilization is ~12% (wet weight). The optimal conversion conditions are 35°C and 6 mL/min of flow rate. Under above conditions, the maximum GM(1) productive strength and conversion ratio can reach to 4.2 g/L·h and 313.5%, respectively. Discussion: Silk fibroin is a promising material for cell immobilization because it has predominant characteristics of higher permeability and intensity. Cell immobilization for continuous GM(1) transformation could eliminate the asialo GM(1) and decrease the foreign matter from transfer medium and metabolism product. Conclusion: In the packed-bed reactor, continuous production of GM(1) had been under effective running at least for 15 days indicating a potential for industrial production. It is significant that this is a first report on cell immobilization for GM(1) production.
H J Dong; J Y Jiang; Q L Chen
Related Documents :
6088108 - Comparison of androgen biosynthesis in isolated leydig cells from rat and mouse testis:...
2539908 - Leydig cell mitoses in human testes bearing early germ cell tumors.
12016218 - Phosphatidylserine binding of class b scavenger receptor type i, a phagocytosis recepto...
8594318 - Androstenedione increases thromboxane a2 receptors in human erythroleukemia cells.
20192768 - Eukaryotic chemotaxis: a network of signaling pathways controls motility, directional s...
17244808 - Growth in catheter biofilms and antibiotic resistance of mycobacterium avium.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-18
Journal Detail:
Title:  Pharmaceutical biology     Volume:  -     ISSN:  1744-5116     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9812552     Medline TA:  Pharm Biol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Research and Design Center, Lunan Pharmaceutical Group Corporation, Linyi, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics...
Next Document:  Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy.